NCT03496259

Brief Summary

Open abdominal and pelvic surgery or thoracotomy (open chest surgery) is frequently performed for tumor excision in children. Post-operative pain management regimens are often at the discretions of the attending surgeon and may include opiods, patient administered analgesia (PCA), epidural catheters, subcutaneous analgesia catheters or NSAIDS to control incisional pain. Currently, both epidural or subcutaneous analgesia catheters (On-Q pumps) are commonly used for children undergoing these operations, at the discretion of the surgeon. There are no studies comparing these regimens in children. The purpose of this study is to compare postoperative pain control of the two strategies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable postoperative-pain

Timeline
Completed

Started Sep 2018

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 12, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

February 3, 2022

Status Verified

January 1, 2022

Enrollment Period

2.8 years

First QC Date

March 30, 2018

Last Update Submit

January 20, 2022

Conditions

Keywords

Postoperative pain, on-Q pump, epidural, children

Outcome Measures

Primary Outcomes (1)

  • Additional narcotic use

    Mg of additional narcotics used for 3 post-operative days

    3 days

Secondary Outcomes (4)

  • Pain scores

    3 days

  • Days to ambulation

    0-5 days

  • Days to initiation of regular diet

    0-5 days

  • Development of postoperative infection

    0-5 days

Study Arms (2)

On-Q Group

EXPERIMENTAL

Patients in this group will have an On-Q pump placed at the end of the operation

Device: On-Q pump

Epidural Group

ACTIVE COMPARATOR

Patients in this group will have an epidural catheter placed at the end of the operation

Device: Epidural catheter

Interventions

On-Q pumpDEVICE

Type of pain control device used

On-Q Group

Type of pain control device used

Epidural Group

Eligibility Criteria

Age3 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Weight \> 5kg
  • Age younger than 19 years of age
  • Planned abdominal, pelvic or thoracic operation for an oncologic indication

You may not qualify if:

  • Patients deemed inappropriate for placement of epidural by anesthesiologist
  • Minimally invasive operation
  • Biopsy through limited incision
  • History of chronic narcotic or opioid use
  • History of drug abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Children's Hospital

Houston, Texas, 77005, United States

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Bindi Naik-Mathuria, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The patient, family and clinical care team (nurses, residents, physician assistants) will be blinded, as well as the research team collecting outcomes. The surgeons (including primary investigator) will not be blinded as will be placing the device.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 30, 2018

First Posted

April 12, 2018

Study Start

September 1, 2018

Primary Completion

June 1, 2021

Study Completion

December 1, 2021

Last Updated

February 3, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations